P
Prime Medicine, Inc.
PRME · NASDAQ · Healthcare · 558M
Closing price
$3.99
+11.45% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.9×
Enterprise value / EBITDAEV/EBITDA
-3.3×
Free cash flow yieldFCF yield
-28.2%
Return on equityROE
-166.4%
Operating margin
-4498.1%
Net debt / EBITDAbalance-sheet strength
-0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.